Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


GNC to license enhanced folate from BASF, plans education efforts for creatine.

This article was originally published in The Tan Sheet

Executive Summary

GNC ENHANCED FOLATE SUPPLEMENT UNDER LICENSE WITH BASF is expected to be introduced in the early fall. General Nutrition Companies will begin selling 400 mcg tablets of methyltetrahydrofolate (5-MTHF) in September or October. The product, a refined version of folic acid, will not make any specific structure/function claims, although labeling will state 5-MTHF has greater bioavailability than traditional folate (vitamin B12). The new GNC supplement will be sold as a stand- alone product in 30-count tablets.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts